NeuroGastrX
Home - Neurogastrx, Inc.
United States · $107.8M raised
- Employees
- 1–10
- Business Model
- B2B
- Website
- neurogastrx.com
- Total Funding
- $107.8M
- Last Round
- $60.0M Series BAug 2021
- Rounds
- 3
About
Late clinical-stage biopharmaceutical company developing therapies for gastrointestinal disorders and unmet GI patient needs.
Summary
NeuroGastrX is a Biotech company based in United States. It has raised $107.8M in total across 3 rounds, most recently a $60.0M Series B round in Aug 2021. Investors include Vivo Capital, 5AM Ventures and OrbiMed.
Tech & App Stack
5 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Aug 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.